Proofpoint Inc (PFPT) Fundamental Analysis & Valuation

NASDAQ:PFPT

Current stock price

175.9
-0.04 (-0.02%)
At close:
175.91
+0.01 (+0.01%)
After Hours:

This PFPT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PFPT Profitability Analysis

1.1 Basic Checks

  • PFPT had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -6.87%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -11.6%
PM (TTM) -15.16%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. PFPT Health Analysis

2.1 Basic Checks

  • PFPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

  • PFPT has an Altman-Z score of 2.57. This is not the best score and indicates that PFPT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • PFPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.57
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • PFPT has a Current Ratio of 1.37. This is a normal value and indicates that PFPT is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.37 indicates that PFPT should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. PFPT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.84% over the past year.
  • PFPT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 55.54% yearly.
  • PFPT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.27%.
  • The Revenue has been growing by 31.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16.84%
EPS 3Y33.84%
EPS 5Y55.54%
EPS Q2Q%23.53%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y26.42%
Revenue growth 5Y31.66%
Sales Q2Q%19.43%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.44% on average over the next years. This is quite good.
  • Based on estimates for the next years, PFPT will show a quite strong growth in Revenue. The Revenue will grow by 15.32% on average per year.
EPS Next Y16.1%
EPS Next 2Y17.24%
EPS Next 3Y15.17%
EPS Next 5Y11.44%
Revenue Next Year18.38%
Revenue Next 2Y18.01%
Revenue Next 3Y16.1%
Revenue Next 5Y15.32%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PFPT Yearly Revenue VS EstimatesPFPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
PFPT Yearly EPS VS EstimatesPFPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

0

4. PFPT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 79.23, which means the current valuation is very expensive for PFPT.
  • When comparing the Price/Earnings ratio of PFPT to the average of the S&P500 Index (26.64), we can say PFPT is valued expensively.
  • Based on the Price/Forward Earnings ratio of 64.31, the valuation of PFPT can be described as expensive.
  • When comparing the Price/Forward Earnings ratio of PFPT to the average of the S&P500 Index (21.36), we can say PFPT is valued expensively.
Industry RankSector Rank
PE 79.23
Fwd PE 64.31
PFPT Price Earnings VS Forward Price EarningsPFPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 108.23
PFPT Per share dataPFPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PFPT does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as PFPT's earnings are expected to grow with 15.17% in the coming years.
PEG (NY)4.92
PEG (5Y)1.43
EPS Next 2Y17.24%
EPS Next 3Y15.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PFPT Dividend Analysis

5.1 Amount

  • No dividends for PFPT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PFPT Fundamentals: All Metrics, Ratios and Statistics

Proofpoint Inc

NASDAQ:PFPT (8/30/2021, 8:56:08 PM)

After market: 175.91 +0.01 (+0.01%)

175.9

-0.04 (-0.02%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)03-01
Inst Owners1.18%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner Change0%
Market Cap10.16B
Revenue(TTM)1.14B
Net Income(TTM)-172.61M
Analysts67.2
Price Target172.47 (-1.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 79.23
Fwd PE 64.31
P/S 8.93
P/FCF N/A
P/OCF N/A
P/B 35.72
P/tB N/A
EV/EBITDA 108.23
EPS(TTM)2.22
EY1.26%
EPS(NY)2.74
Fwd EY1.56%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS19.71
BVpS4.92
TBVpSN/A
PEG (NY)4.92
PEG (5Y)1.43
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.87%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -11.6%
PM (TTM) -15.16%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 2.57
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.84%
EPS 3Y33.84%
EPS 5Y55.54%
EPS Q2Q%23.53%
EPS Next Y16.1%
EPS Next 2Y17.24%
EPS Next 3Y15.17%
EPS Next 5Y11.44%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y26.42%
Revenue growth 5Y31.66%
Sales Q2Q%19.43%
Revenue Next Year18.38%
Revenue Next 2Y18.01%
Revenue Next 3Y16.1%
Revenue Next 5Y15.32%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Proofpoint Inc / PFPT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Proofpoint Inc (PFPT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PFPT.


What is the valuation status for PFPT stock?

ChartMill assigns a valuation rating of 0 / 10 to Proofpoint Inc (PFPT). This can be considered as Overvalued.


What is the profitability of PFPT stock?

Proofpoint Inc (PFPT) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for PFPT stock?

The Earnings per Share (EPS) of Proofpoint Inc (PFPT) is expected to grow by 16.1% in the next year.


Is the dividend of Proofpoint Inc sustainable?

The dividend rating of Proofpoint Inc (PFPT) is 0 / 10 and the dividend payout ratio is 0%.